Is Waters Corporation (WAT) overvalued or fairly valued?

MarketChacha shows Waters Corporation's valuation in context — a forward P/E of about 22.5, a price-to-book of about 2.4 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Waters Corporation (WAT)?

Waters Corporation last traded at $371.47 (+1.1% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Waters Corporation

WAT · NYSE · Healthcare · United States

$371.47+1.1%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:36 PM

Snapshot

TickerWAT

ExchangeNYSE

SectorHealthcare

IndustryDiagnostics & Research

CountryUnited States

Employees16,000

HeadquartersMilford, United States

Market cap$36.5B

P/B2.4

Volume430.77K

Websitewww.waters.com

Filings tracked0

About Waters Corporation

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.1%
Institutions99.9%
Public & other0.0%

1,591 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.8.70%
Vanguard Capital Management LLC6.50%
Vanguard Portfolio Management LLC4.84%
T. Rowe Price Investment Management, Inc.4.75%
Massachusetts Financial Services Co.4.72%
State Street Corporation4.44%
Fundsmith LLP3.27%
Geode Capital Management, LLC2.70%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $1.8B · EPS 3.99

Est. earnings growth +17.4%

Next fiscal year

Rev $7.1B · EPS 16.49

Est. earnings growth +13.6%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$275.0552-wk range$414.15

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about WAT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.